Protara Therapeutic Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.55

-0.15 (-4.05%)

As of Sep 20, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +560.3% upside

Low Target $15.10

Average Target $23.44

High Target $28.04

Current Price $3.55

Current
$3.55

Target
$23.44

$15.10 $23.44 avg $28.04

Scenario Analysis

Bear Case

$15.10

325.4%

Low target

Base Case

$23.44

+560.3%

Avg target

Bull Case

$28.04

+689.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$7.82

-54.6% from high

52-Week Low

$3.02

+17.5% from low

Target vs 52W High

$23.44

+199.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%